Juventas Cell Therapy Ltd.

State Grid Corporation of China

State Grid Tianjin Electric Power Company

Electric Power Science & Research Institute of State Grid Tianjin Electric Power Company

Yun Liu

Rui Wang

Lulu Lv

Lin Shi

Fei Wang

Pan Xie

Mengmeng Cao

Wang Yang

Jiaxing Yang

Yi Ding

Xianxu Huo

Shiqian Ma

Lei Wu

Tianhao Wang

Jianxiang Wang

Bin Wu

Min Wang

Na An

Provided in the present disclosure is a method for using a four-plasmid system to prepare modified immune effector cells. The method comprises: forming a lentivirus by using four plasmids within 293T cells, extracting and obtaining the lentivirus, then transfecting immune effector cells by using the lentivirus, and expressing a chimeric antigen receptor. Also provided in the present disclosure is a use of the immune effector cell obtained by using the described method and of a composition containing the immune effector cell.

Plasmid combination and application thereof in preparing modified immune cells

A method for making a spatio-temporal combined optimal scheduling strategy of a mobile energy storage (MES) system includes: inputting data of a power system, a traffic system, and an MES system; setting a time interval, and initializing a time interval counter; inputting real-time fault, traffic, and MES data; and performing rolling optimization and solving, and delivering regulation decision instructions of the MES system, till a fault is removed. The core of the present disclosure is to propose a spatio-temporal combined optimal model of the MES system to describe spatio-temporal coupling statuses of an energy storage vehicle, a traffic network, and a power distribution network. The present disclosure provides guidance for an optimal scheduling decision of the MES system by properly regulating a traveling path and charging and discharging power of the MES system, thereby supporting high-reliability operation of the power distribution network.

Method for making spatio-temporal combined optimal scheduling strategy of mobile energy storage (MES) system

A chimeric antigen receptor, comprising an amino acid sequence shown in SEQ ID NO. 1. A nucleic acid encoding the chimeric antigen receptor, a vector comprising the nucleic acid, an immune effector cell comprising the chimeric antigen receptor, the nucleic acid molecule and/or the vector, a method for preparing the immune effector cell, a composition comprising the immune effector cell, and use of the chimeric antigen receptor.

CD19-targeted chimeric antigen receptor and use thereof

Growing community of inventors

Tianjin, China

Yun Liu